查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1590849

糖化血红素测试市场：按类型、方法和最终用户划分 - 2025-2030 年全球预测

Glycated Hemoglobin Testing Market by Type (Laboratory Based Tests, Point-Of-Care Test), Technique (Boronate Affinity Chromatography, Direct Enzymatic Assay, High-Performance Liquid Chromatography), End-User - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 192 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2023年糖化血红素检测市值为6.8636亿美元，预计到2024年将达到7.5413亿美元，复合年增长率为9.96%，预计到2030年将达到13.3483亿美元。

糖化血红蛋白测试（通常称为 HbA1c 测试）透过测量平均血糖值（通常在 2-3 个月内）在糖尿病管理中发挥至关重要的作用。此测试对于诊断和监测糖尿病、确定治疗策略以及降低併发症的风险极为重要。全球糖尿病和糖尿病前期盛行率的不断上升凸显了其需求，导致其应用不仅在医院和诊断实验室，而且在居家照护环境中不断扩大。最终用途包括糖尿病患者、医疗保健提供者，甚至寻求先进糖尿病管理策略的研究机构。影响成长的关键因素包括医疗保健支出增加、检测方法的技术进步、消费者对糖尿病护理意识的提高以及政府的支持政策。随着市场的发展，就地检验设备的整合和远端医疗解决方案的发展带来了潜在的机会，以满足对方便、及时的诊断不断增长的需求。为了抓住这些机会，公司应该专注于开发用户友好且具有成本效益的测试解决方案，并利用数位平台进行更广泛的推广和资料整合。然而，监管限制、先进测试技术的高成本以及新兴市场意识的缺乏等限制因素给市场扩张带来了挑战。此外，对现场护理设备准确性的担忧可能会阻碍市场接受度。因此，技术创新应着重于提高检测精度、降低成本、开发非侵入性检测技术。市场本质上是动态的，其特点是技术不断进步和竞争激烈，领先企业努力创新并赢得市场占有率。随时了解消费者需求和监管趋势可以帮助相关人员克服挑战，并为成长铺平道路，以在糖化血红蛋白测试市场取得持续成功。

主要市场统计
基准年[2023] 68636万美元
预测年份 [2024] 75413万美元
预测年份 [2030] 1,334.83百万美元
复合年增长率（%） 9.96%

市场动态：快速发展的糖化血红蛋白测试市场的关键市场洞察

供需的动态交互作用正在改变糖化血红蛋白检测市场。透过了解这些不断变化的市场动态，公司可以准备好做出明智的投资决策、完善策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，同时也能帮助消费行为及其对製造业的影响。

  • 市场驱动因素
    • 糖尿病等各种慢性病的全球盛行率不断上升
    • 由于人口老化加剧，人们更容易罹患疾病
    • 快速采用患者自我护理解决方案
  • 市场限制因素
    • 糖化血红素检测设备的高成本
  • 市场机会
    • 家庭医疗保健市场的需求不断增长，包括快速诊断测试和 PCOT
    • 持续进行早期诊断和有效疾病管理的研究和开发活动
  • 市场挑战
    • HbA1c 检测的限制和替代方案的可用性

波特五力：驾驭糖化血红素测试市场的策略工具

波特的五力框架是理解市场竞争格局的重要工具。波特的五力框架为评估公司的竞争地位和探索策略机会提供了清晰的方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势，解决弱点并避免潜在的挑战，从而确保更强大的市场地位。

PESTLE分析：了解糖化血红素测试市场的外部影响

外部宏观环境因素在塑造糖化血红蛋白测试市场的绩效动态方面发挥着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助企业预测法规、消费者偏好和经济趋势的变化，并为他们做出积极主动的决策做好准备。

市场占有率分析 了解糖化血红素检测市场的竞争状况

糖化血红素测试市场的详细市场占有率分析可以对供应商的绩效进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示其竞争地位。该分析揭示了市场集中、分散和整合的趋势，为供应商提供了製定策略决策所需的洞察力，使他们能够在日益激烈的竞争中占有一席之地。

FPNV定位矩阵糖化血红素检测市场供应商的绩效评估

FPNV定位矩阵是评估糖化血红素检测市场供应商的重要工具。此矩阵允许业务组织根据供应商的商务策略和产品满意度评估供应商，从而做出符合其目标的明智决策。这四个象限使您能够清晰、准确地划分供应商，并确定最能满足您的策略目标的合作伙伴和解决方案。

策略分析和建议绘製糖化血红蛋白测试市场的成功之路

对于旨在加强在全球市场的影响力的公司来说，糖化血红蛋白测试市场的策略分析至关重要。透过审查关键资源、能力和绩效指标，公司可以识别成长机会并努力改进。这种方法使您能够克服竞争环境中的挑战，利用新的商机并取得长期成功。

本报告对市场进行了全面分析，涵盖关键重点领域：

1. 市场渗透率：详细检视当前市场环境、主要企业的广泛资料、评估其在市场中的影响力和整体影响力。

2. 市场开拓：辨识新兴市场的成长机会，评估现有领域的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、开拓地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报：彻底分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监理核准、专利趋势、主要企业的技术进步等。

5. 产品开发与创新：重点在于有望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，帮助相关人员做出明智的决策：

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品、区隔市场和地区提供最佳投资机会？

3.塑造市场的主要技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 在世界范围内，糖尿病等各种慢性疾病的发生率正在增加。
      • 老年人口的增加导致疾病的脆弱性增加
      • 患者自我护理解决方案迅速普及
    • 抑制因素
      • 糖化血红素检测设备的高成本
    • 机会
      • 家庭医疗保健市场的新需求包括快速诊断测试和PCOT
      • 持续进行早期诊断和有效疾病管理的研究和开发活动
    • 任务
      • HbA1c 检测的限制和替代方案的可用性
  • 市场区隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 经济
    • 社群
    • 技术的
    • 合法地
    • 环境

第六章糖化血红蛋白测试市场：按类型

  • 基于实验室的测试
  • 照护现场测试

第七章糖化血红素测试市场：依技术分类

  • 硼酸盐亲和层析法
  • 直接酶测定
  • 高效液相层析
  • 免疫检测

第 8 章 糖化血红素测试市场：依最终用户分类

  • 学术研究所
  • 诊断中心
  • 医院

第九章 北美、南美糖化血红素检测市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第十章亚太地区糖化血红素检测市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十一章 欧洲、中东、非洲糖化血红素检测市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十二章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
  • 战略分析和建议

公司名单

  • A. Menarini Diagnostics srl
  • Abbott Laboratories Inc.
  • ARKRAY, Inc.
  • Beckman Coulter, Inc.
  • Bio-Rad Laboratories, Inc.
  • Daiichi Biotech Services Sdn. Bhd.
  • Danaher Corporation
  • DiaSys Diagnostic Systems GmbH
  • Diazyme Laboratories, Inc.
  • EKF Diagnostics Holdings plc
  • F. Hoffmann-La Roche AG
  • Sebia
  • Siemens AG
  • TaiDoc Technology Corporation
  • Tosoh Corporation
  • Trinity Biotech
Product Code: MRR-4349B3591E79

The Glycated Hemoglobin Testing Market was valued at USD 686.36 million in 2023, expected to reach USD 754.13 million in 2024, and is projected to grow at a CAGR of 9.96%, to USD 1,334.83 million by 2030.

Glycated hemoglobin testing, often referred to as HbA1c testing, plays a pivotal role in diabetes management by measuring average blood glucose levels over a period, typically 2-3 months. This test is crucial for diagnosing and monitoring diabetes, guiding therapeutic decisions, and reducing the risk of complications. Its necessity is underscored by the increasing global prevalence of diabetes and prediabetes, thus expanding its application not only in hospitals and diagnostic labs but also in home-care settings. The end-use scope encompasses individuals with diabetes, healthcare providers, and even research institutions exploring advanced diabetes management strategies. Key influencing growth factors include rising healthcare expenditure, technological advancements in testing methods, increased consumer awareness regarding diabetic care, and supportive governmental policies. As the market evolves, potential opportunities arise from the integration of point-of-care testing devices and the growth of telemedicine solutions, which align with the increasing demand for convenient and timely diagnostics. To seize these opportunities, businesses should focus on developing user-friendly, cost-effective testing solutions and leverage digital platforms for wider outreach and data integration. However, limitations such as regulatory constraints, high costs associated with advanced testing technologies, and a lack of awareness in developing regions pose challenges to market expansion. Additionally, accuracy concerns with point-of-care devices can impede market acceptance. Innovation should therefore focus on enhancing test accuracy, reducing costs, and developing non-invasive testing techniques. The market is inherently dynamic, characterized by continuous technological progression and intense competition, with major players striving to innovate and capture market share. By staying attuned to consumer needs and regulatory developments, stakeholders can navigate challenges and leverage growth avenues for sustained success in the glycated hemoglobin testing market.

KEY MARKET STATISTICS
Base Year [2023] USD 686.36 million
Estimated Year [2024] USD 754.13 million
Forecast Year [2030] USD 1,334.83 million
CAGR (%) 9.96%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Glycated Hemoglobin Testing Market

The Glycated Hemoglobin Testing Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Increasing incidence of various chronic diseases such as diabetes globally
    • Rising geriatric population leads to higher vulnerability for diseases
    • Rapid adoption attributed to patient self-care solutions
  • Market Restraints
    • High cost pertinent to glycated hemoglobin testing equipment
  • Market Opportunities
    • Emerging demand for home healthcare market such as rapid diagnostic tests and PCOT
    • Ongoing R&D activities for early diagnosis and efficient disease management
  • Market Challenges
    • Limitation of HbA1c tests and availability of substitutes

Porter's Five Forces: A Strategic Tool for Navigating the Glycated Hemoglobin Testing Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Glycated Hemoglobin Testing Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Glycated Hemoglobin Testing Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Glycated Hemoglobin Testing Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Glycated Hemoglobin Testing Market

A detailed market share analysis in the Glycated Hemoglobin Testing Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Glycated Hemoglobin Testing Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Glycated Hemoglobin Testing Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Glycated Hemoglobin Testing Market

A strategic analysis of the Glycated Hemoglobin Testing Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Glycated Hemoglobin Testing Market, highlighting leading vendors and their innovative profiles. These include A. Menarini Diagnostics s.r.l, Abbott Laboratories Inc., ARKRAY, Inc., Beckman Coulter, Inc., Bio-Rad Laboratories, Inc., Daiichi Biotech Services Sdn. Bhd., Danaher Corporation, DiaSys Diagnostic Systems GmbH, Diazyme Laboratories, Inc., EKF Diagnostics Holdings plc, F. Hoffmann-La Roche AG, Sebia, Siemens AG, TaiDoc Technology Corporation, Tosoh Corporation, and Trinity Biotech.

Market Segmentation & Coverage

This research report categorizes the Glycated Hemoglobin Testing Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Type, market is studied across Laboratory Based Tests and Point-Of-Care Test.
  • Based on Technique, market is studied across Boronate Affinity Chromatography, Direct Enzymatic Assay, High-Performance Liquid Chromatography, and Immunoassay.
  • Based on End-User, market is studied across Academic & Research Institutes, Diagnostic Centers, and Hospitals.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing incidence of various chronic diseases such as diabetes globally
      • 5.1.1.2. Rising geriatric population leads to higher vulnerability for diseases
      • 5.1.1.3. Rapid adoption attributed to patient self-care solutions
    • 5.1.2. Restraints
      • 5.1.2.1. High cost pertinent to glycated hemoglobin testing equipment
    • 5.1.3. Opportunities
      • 5.1.3.1. Emerging demand for home healthcare market such as rapid diagnostic tests and PCOT
      • 5.1.3.2. Ongoing R&D activities for early diagnosis and efficient disease management
    • 5.1.4. Challenges
      • 5.1.4.1. Limitation of HbA1c tests and availability of substitutes
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Glycated Hemoglobin Testing Market, by Type

  • 6.1. Introduction
  • 6.2. Laboratory Based Tests
  • 6.3. Point-Of-Care Test

7. Glycated Hemoglobin Testing Market, by Technique

  • 7.1. Introduction
  • 7.2. Boronate Affinity Chromatography
  • 7.3. Direct Enzymatic Assay
  • 7.4. High-Performance Liquid Chromatography
  • 7.5. Immunoassay

8. Glycated Hemoglobin Testing Market, by End-User

  • 8.1. Introduction
  • 8.2. Academic & Research Institutes
  • 8.3. Diagnostic Centers
  • 8.4. Hospitals

9. Americas Glycated Hemoglobin Testing Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Glycated Hemoglobin Testing Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Glycated Hemoglobin Testing Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
  • 12.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. A. Menarini Diagnostics s.r.l
  • 2. Abbott Laboratories Inc.
  • 3. ARKRAY, Inc.
  • 4. Beckman Coulter, Inc.
  • 5. Bio-Rad Laboratories, Inc.
  • 6. Daiichi Biotech Services Sdn. Bhd.
  • 7. Danaher Corporation
  • 8. DiaSys Diagnostic Systems GmbH
  • 9. Diazyme Laboratories, Inc.
  • 10. EKF Diagnostics Holdings plc
  • 11. F. Hoffmann-La Roche AG
  • 12. Sebia
  • 13. Siemens AG
  • 14. TaiDoc Technology Corporation
  • 15. Tosoh Corporation
  • 16. Trinity Biotech

LIST OF FIGURES

  • FIGURE 1. GLYCATED HEMOGLOBIN TESTING MARKET RESEARCH PROCESS
  • FIGURE 2. GLYCATED HEMOGLOBIN TESTING MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL GLYCATED HEMOGLOBIN TESTING MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY TECHNIQUE, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY TECHNIQUE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. AMERICAS GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 13. AMERICAS GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. UNITED STATES GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 15. UNITED STATES GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. ASIA-PACIFIC GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. ASIA-PACIFIC GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. GLYCATED HEMOGLOBIN TESTING MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 21. GLYCATED HEMOGLOBIN TESTING MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. GLYCATED HEMOGLOBIN TESTING MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL GLYCATED HEMOGLOBIN TESTING MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. GLYCATED HEMOGLOBIN TESTING MARKET DYNAMICS
  • TABLE 7. GLOBAL GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY LABORATORY BASED TESTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY POINT-OF-CARE TEST, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY BORONATE AFFINITY CHROMATOGRAPHY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY DIRECT ENZYMATIC ASSAY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY HIGH-PERFORMANCE LIQUID CHROMATOGRAPHY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY IMMUNOASSAY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY DIAGNOSTIC CENTERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. AMERICAS GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 20. AMERICAS GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 21. AMERICAS GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 22. AMERICAS GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 23. ARGENTINA GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 24. ARGENTINA GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 25. ARGENTINA GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 26. BRAZIL GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 27. BRAZIL GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 28. BRAZIL GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 29. CANADA GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 30. CANADA GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 31. CANADA GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 32. MEXICO GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 33. MEXICO GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 34. MEXICO GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 35. UNITED STATES GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 36. UNITED STATES GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 37. UNITED STATES GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 38. UNITED STATES GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 39. ASIA-PACIFIC GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 40. ASIA-PACIFIC GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 41. ASIA-PACIFIC GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 42. ASIA-PACIFIC GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 43. AUSTRALIA GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 44. AUSTRALIA GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 45. AUSTRALIA GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 46. CHINA GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 47. CHINA GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 48. CHINA GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 49. INDIA GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 50. INDIA GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 51. INDIA GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 52. INDONESIA GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 53. INDONESIA GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 54. INDONESIA GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 55. JAPAN GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 56. JAPAN GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 57. JAPAN GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 58. MALAYSIA GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 59. MALAYSIA GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 60. MALAYSIA GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 61. PHILIPPINES GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 62. PHILIPPINES GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 63. PHILIPPINES GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 64. SINGAPORE GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 65. SINGAPORE GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 66. SINGAPORE GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 67. SOUTH KOREA GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 68. SOUTH KOREA GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 69. SOUTH KOREA GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 70. TAIWAN GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 71. TAIWAN GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 72. TAIWAN GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 73. THAILAND GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 74. THAILAND GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 75. THAILAND GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 76. VIETNAM GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 77. VIETNAM GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 78. VIETNAM GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 79. EUROPE, MIDDLE EAST & AFRICA GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 80. EUROPE, MIDDLE EAST & AFRICA GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 81. EUROPE, MIDDLE EAST & AFRICA GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 82. EUROPE, MIDDLE EAST & AFRICA GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 83. DENMARK GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 84. DENMARK GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 85. DENMARK GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 86. EGYPT GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 87. EGYPT GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 88. EGYPT GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 89. FINLAND GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 90. FINLAND GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 91. FINLAND GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 92. FRANCE GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 93. FRANCE GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 94. FRANCE GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 95. GERMANY GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 96. GERMANY GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 97. GERMANY GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 98. ISRAEL GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 99. ISRAEL GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 100. ISRAEL GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 101. ITALY GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 102. ITALY GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 103. ITALY GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 104. NETHERLANDS GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 105. NETHERLANDS GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 106. NETHERLANDS GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 107. NIGERIA GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 108. NIGERIA GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 109. NIGERIA GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 110. NORWAY GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 111. NORWAY GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 112. NORWAY GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 113. POLAND GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 114. POLAND GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 115. POLAND GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 116. QATAR GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 117. QATAR GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 118. QATAR GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 119. RUSSIA GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 120. RUSSIA GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 121. RUSSIA GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 122. SAUDI ARABIA GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 123. SAUDI ARABIA GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 124. SAUDI ARABIA GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 125. SOUTH AFRICA GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 126. SOUTH AFRICA GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 127. SOUTH AFRICA GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 128. SPAIN GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 129. SPAIN GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 130. SPAIN GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 131. SWEDEN GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 132. SWEDEN GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 133. SWEDEN GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 134. SWITZERLAND GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 135. SWITZERLAND GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 136. SWITZERLAND GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 137. TURKEY GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 138. TURKEY GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 139. TURKEY GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 140. UNITED ARAB EMIRATES GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 141. UNITED ARAB EMIRATES GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 142. UNITED ARAB EMIRATES GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 143. UNITED KINGDOM GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 144. UNITED KINGDOM GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 145. UNITED KINGDOM GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 146. GLYCATED HEMOGLOBIN TESTING MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 147. GLYCATED HEMOGLOBIN TESTING MARKET, FPNV POSITIONING MATRIX, 2023